151 related articles for article (PubMed ID: 10982540)
1. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
[TBL] [Abstract][Full Text] [Related]
2. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
Locht H; Wiik A
Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
[TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
4. Anticardiolipin antibodies are no marker for survived myocardial infarction.
Eber B; Kronberger-Schaffer E; Brussee H; Klima G; Obernosterer A; Toporsch M; Dusleag J; Klein W
Klin Wochenschr; 1990 Jun; 68(12):594-6. PubMed ID: 2376955
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits.
Avcin T; Ambrozic A; Kuhar M; Kveder T; Rozman B
Rheumatology (Oxford); 2001 May; 40(5):565-73. PubMed ID: 11371668
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy.
Valdés-Macho E; Cabiedes J; Villa AR; Cabral AR; Alarcón-Segovia D
Arch Med Res; 2002; 33(5):460-5. PubMed ID: 12459316
[TBL] [Abstract][Full Text] [Related]
7. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke.
Sletnes KE; Smith P; Abdelnoor M; Arnesen H; Wisløff F
Lancet; 1992 Feb; 339(8791):451-3. PubMed ID: 1346819
[TBL] [Abstract][Full Text] [Related]
9. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
13. Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.
Halacheva K; Dimova S; Tolev T; Dimov D; Nikolova M
Psychiatry Res; 2009 Aug; 169(1):51-5. PubMed ID: 19596154
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
15. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.
Gürlek A; Ozdöl C; Pamir G; Dinçer I; Tutkak H; Oral D
Int Heart J; 2005 Jul; 46(4):631-8. PubMed ID: 16157954
[TBL] [Abstract][Full Text] [Related]
16. Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty.
Eber B; Schumacher M; Auer-Grumbach P; Toplak H; Klein W
Am J Cardiol; 1992 May; 69(16):1255-8. PubMed ID: 1585855
[TBL] [Abstract][Full Text] [Related]
17. Location of recurrent cardiovascular events and anticardiolipin antibodies.
Galán-González J; Rico-Martín S; Calderón-García JF; Antón J; Ramírez-Moreno JM; Álvarez-Rodríguez LR; Sánchez Muñoz-Torrero JF;
Eur J Clin Invest; 2021 Jul; 51(7):e13533. PubMed ID: 33666941
[TBL] [Abstract][Full Text] [Related]
18. Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome.
Audrain MA; El-Kouri D; Hamidou MA; Mioche L; Ibara A; Langlois ML; Muller JY
Rheumatology (Oxford); 2002 May; 41(5):550-3. PubMed ID: 12011379
[TBL] [Abstract][Full Text] [Related]
19. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
20. Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis.
Loizou S; Samarkos M; Norsworthy PJ; Cazabon JK; Walport MJ; Davies KA
Rheumatology (Oxford); 2000 Sep; 39(9):962-8. PubMed ID: 10986300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
